Cleveland Clinic highlights imaging innovations

Cleveland Clinic has released its annual Top 10 Medical Innovations for 2011 list, which includes devices that employ imaging and informatics to enable better healthcare.

A panel of Cleveland Clinic physicians and scientists selected the devices and therapies, and unveiled them during the provider’s 2010 Medical Innovation Summit.

Among its Top 10 were:
# 10. Capsule endoscopy for diagnosis of pediatric GI disorders: A pill-sized camera captures 50,000 high-resolution images during its painless six- to eight-hour journey through the digestive tract, proving better than x-ray at detecting small bowel ulcerations, polyps and areas of bleeding.

# 6. Telehealth monitoring for heart failure patients: Miniature implantable monitors to measure pulmonary artery pressure daily and at-home devices to monitor weight, heart rate and blood pressure of heart failure patients allow doctors to adjust medication quickly, improving patient outcomes, while reducing re-hospitalizations.

#1. New molecular imaging biomarker for early detection of Alzheimer's disease: Currently, positive diagnosis of Alzheimer's is only possible upon autopsy. But a radioactive molecular imaging compound called AV-45 and a PET scan can allow doctors to "see" inside patients' brains to detect beta-amyloid plaques, the tell-tale signature of Alzheimer's.

    The Top 10 Medical Innovations had to meet four major criteria for qualification and selection, which included:
    • Significant potential for short-term clinical impact (either a major improvement in patient benefit or an improved function that enhances healthcare delivery);
    • High probability of success;
    • On the market or close to being introduced; and
    • Sufficient data available to support its nomination.

    Around the web

    The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

    Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
     

    The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.